Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Eravacycline in ESRD and Healthy Subjects
NCT02135276Phase 1Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Dec 2013
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label trial of eravacycline in Intra-abdominal infection (IAI) (2 arms), sponsored by Tetraphase Therapeutics. Primary endpoint: Pharmacokinetic profile of eravacycline at 5 days. Started Dec 2013; status: completed.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT02135276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135276.